The latest research articles published by Annals of Clinical Microbiology and Antimicrobials
12 followers 0 articles/week
Antibacterial activity of recently approved antibiotics against methicillin-resistant Staphylococcus aureus (MRSA) strains: A systematic review and meta-analysis

Methicillin-resistant Staphylococcus aureus (MRSA) infections are considered an important public health problem, and treatment options are limited. Accordingly, in this meta-analysis, we analyzed published studie...

Wed Aug 17, 2022 21:19
Clinical features, hospitalisation and deaths associated with monkeypox: a systematic review and meta-analysis

A multicountry monkeypox disease (MPX) outbreak began in May 2022 in Europe, leading to the assessment as a potential Public Health Emergency of International Concern (PHEIC) on June 23, 2022. Some observation...

Wed Aug 10, 2022 19:01
Molecular determination of O25b/ST131 clone type among extended spectrum β-lactamases production Escherichia coli recovering from urinary tract infection isolates

Escherichia coli (E. coli) O25b/ST131 clone causes urinary tract infection (UTI) and is associated with a broad spectrum of other infections, such as intra-abdominal and soft tissue infections, that can be affect...

Thu Aug 4, 2022 17:12
A case report and review of acute cholangitis with septic shock induced by Edwardsiella tarda

Edwardsiella tarda (E. tarda) is a gram-negative facultative anaerobic bacterium. Gastroenteritis is the most common manifestation of E. tarda infection. However, parenteral infections can occur in immunodeficie...

Tue Jul 5, 2022 19:06
COVID-19 vaccination efficacy in numbers including SARS-CoV-2 variants and age comparison: a meta-analysis of randomized clinical trials

New vaccines are being developed to fight the ongoing COVID-19 pandemic. In our study we compared the efficacy of COVID-19 vaccines to prevent COVID-19-related infections and mortality.

Sun Jul 3, 2022 17:50

Build your own newsfeed

Ready to give it a go?
Start a 14-day trial, no credit card required.

Create account